RAFAEL SIERRA CAMERINO-rekin lankidetzan egindako argitalpenak (10)

2020

  1. Outcomes of the PIRASOA programme, an antimicrobial stewardship programme implemented in hospitals of the Public Health System of Andalusia, Spain: an ecologic study of time-trend analysis

    Clinical Microbiology and Infection, Vol. 26, Núm. 3, pp. 358-365

2019

  1. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): An investigator-driven, open-label, randomized, noninferiority controlled trial

    Critical Care, Vol. 23, Núm. 1

  2. The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection

    Intensive Care Medicine, Vol. 45, Núm. 12, pp. 1753-1762

2018

  1. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

    Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344

  2. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

  3. Initial antifungal strategy reduces mortality in critically ill patients with candidemia: A propensity score-adjusted analysis of a multicenter study

    Critical Care Medicine, Vol. 46, Núm. 3, pp. 384-393

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2015

  1. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): A multicentre, prospective, observational study

    The Lancet Respiratory Medicine, Vol. 3, Núm. 11, pp. 859-868

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1

2011

  1. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386